Capizzi methotrexate with BFM backbone without craniospinal irradiation is effective treatment for pediatric lymphoblastic lymphoma: results from 5 countries with I-BFM LL 09 protocol
| Authors | |
|---|---|
| Year of publication | 2015 |
| Type | Conference abstract |
| MU Faculty or unit | |
| Citation | |
| Description | Lymphoblastic lymphoma represents 20% of all pediatric Non-Hodgkin lymphomas. The outcome of patients with LL has not improved during the last two decades, both due to disease progressions and treatment-related toxicity. |